Literature DB >> 26097587

Cullin1 is up-regulated and associated with poor patients' survival in hepatocellular carcinoma.

Wen Liu1, You Wang2, Chuanling Zhang1, Baoshan Huang1, Jin Bai3, Lijun Tian1.   

Abstract

Cullin1 (Cul1) is a scaffold protein of the ubiquitin E3 ligase Skp1/Cullin1/Rbx1/F-box protein complex, which ubiquitinates a broad range of proteins involved in cell-cycle progression, signal transduction, and transcription. To investigate the role of Cul1 in the development of hepatocellular carcinoma (HCC), we evaluated the Cul1 expression by immunohistochemistry using a tissue microarray (TMA) containing 90 cases HCC tissues and paired adjacent non-cancerous tissues. We analyzed the correlation between Cul1 expression and clinicopathologic variables and patients survival using two independent HCC cohorts TMA. Our data showed that Cul1 expression was apparently increased in HCC tissues compared with paired adjacent non-tumor tissues. We also demonstrated that Cul1 staining was significantly correlated with tumor size, histology grade and TNM stage. Furthermore, we showed a strong correlation between high Cul1 expression and worse 5-year overall and disease-specific survival rates in HCC patients. Finally, univariate and multivariate Cox proportional hazards regression analysis investigated that high Cul1 expression was a strong independent prognostic indicator of HCC. Our data indicated that Cul1 may be an important prognosis marker for human HCC.

Entities:  

Keywords:  Cullin1; hepatocellular carcinoma; immunohistochemistry; prognostic; tissue microarray

Mesh:

Substances:

Year:  2015        PMID: 26097587      PMCID: PMC4466974     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  20 in total

Review 1.  Ubiquitin ligases: cell-cycle control and cancer.

Authors:  Keiichi I Nakayama; Keiko Nakayama
Journal:  Nat Rev Cancer       Date:  2006-05       Impact factor: 60.716

2.  Cip/Kip proteins: more than just CDKs inhibitors.

Authors:  Catherine Denicourt; Steven F Dowdy
Journal:  Genes Dev       Date:  2004-04-15       Impact factor: 11.361

3.  Cul1 expression is increased in early stages of human melanoma.

Authors:  Guangdi Chen; Yabin Cheng; Magdalena Martinka; Gang Li
Journal:  Pigment Cell Melanoma Res       Date:  2010-05-31       Impact factor: 4.693

Review 4.  Cancer metastasis: building a framework.

Authors:  Gaorav P Gupta; Joan Massagué
Journal:  Cell       Date:  2006-11-17       Impact factor: 41.582

5.  Increased Cul1 expression promotes melanoma cell proliferation through regulating p27 expression.

Authors:  Guangdi Chen; Gang Li
Journal:  Int J Oncol       Date:  2010-11       Impact factor: 5.650

6.  [Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue].

Authors:  W Remmele; H E Stegner
Journal:  Pathologe       Date:  1987-05       Impact factor: 1.011

7.  Overexpression of Cullin1 is associated with poor prognosis of patients with gastric cancer.

Authors:  Jin Bai; Yan Zhou; Guangdi Chen; Jinyan Zeng; Jingjing Ding; Yongfei Tan; Jianwei Zhou; Gang Li
Journal:  Hum Pathol       Date:  2010-12-28       Impact factor: 3.466

8.  Altered pattern of Cul-1 protein expression and neddylation in human lung tumours: relationships with CAND1 and cyclin E protein levels.

Authors:  C Salon; E Brambilla; C Brambilla; S Lantuejoul; S Gazzeri; B Eymin
Journal:  J Pathol       Date:  2007-11       Impact factor: 7.996

Review 9.  Uterine cervical carcinoma: role of matrix metalloproteinases (review).

Authors:  Massimo Libra; Aurora Scalisi; Nadia Vella; Silvia Clementi; Roberto Sorio; Franca Stivala; Demetrios A Spandidos; Clorinda Mazzarino
Journal:  Int J Oncol       Date:  2009-04       Impact factor: 5.650

10.  Sorafenib in advanced hepatocellular carcinoma.

Authors:  Josep M Llovet; Sergio Ricci; Vincenzo Mazzaferro; Philip Hilgard; Edward Gane; Jean-Frédéric Blanc; Andre Cosme de Oliveira; Armando Santoro; Jean-Luc Raoul; Alejandro Forner; Myron Schwartz; Camillo Porta; Stefan Zeuzem; Luigi Bolondi; Tim F Greten; Peter R Galle; Jean-François Seitz; Ivan Borbath; Dieter Häussinger; Tom Giannaris; Minghua Shan; Marius Moscovici; Dimitris Voliotis; Jordi Bruix
Journal:  N Engl J Med       Date:  2008-07-24       Impact factor: 91.245

View more
  5 in total

Review 1.  Neddylation, a novel paradigm in liver cancer.

Authors:  Teresa Cardoso Delgado; Lúcia Barbier-Torres; Imanol Zubiete-Franco; Fernando Lopitz-Otsoa; Marta Varela-Rey; David Fernández-Ramos; María-Luz Martínez-Chantar
Journal:  Transl Gastroenterol Hepatol       Date:  2018-06-30

2.  The expression of Cullin1 is increased in renal cell carcinoma and promotes cancer cell proliferation, migration, and invasion.

Authors:  Ji-Gen Ping; Fei Wang; Jin-Xian Pu; Ping-Fu Hou; Yan-Su Chen; Jin Bai; Jun-Nian Zheng
Journal:  Tumour Biol       Date:  2016-07-23

3.  SESN2 correlates with advantageous prognosis in hepatocellular carcinoma.

Authors:  Shaosen Chen; Weigang Yan; Weiya Lang; Jing Yu; Li Xu; Xinyu Xu; Yunlong Liu; Hongguang Bao
Journal:  Diagn Pathol       Date:  2017-01-24       Impact factor: 2.644

4.  CUL1 promotes breast cancer metastasis through regulating EZH2-induced the autocrine expression of the cytokines CXCL8 and IL11.

Authors:  Ye-Fei Huang; Zhe Zhang; Meng Zhang; Yan-Su Chen; Jun Song; Ping-Fu Hou; Hong-Mei Yong; Jun-Nian Zheng; Jin Bai
Journal:  Cell Death Dis       Date:  2018-12-18       Impact factor: 8.469

5.  CUL1-Mediated Organelle Fission Pathway Inhibits the Development of Chronic Obstructive Pulmonary Disease.

Authors:  Ran Li; Feng Xu; Xiao Wu; Shaoping Ji; Ruixue Xia
Journal:  Comput Math Methods Med       Date:  2020-05-26       Impact factor: 2.238

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.